Down-regulation of the M6P/IGF-II receptor increases cell proliferation and reduces apoptosis in neonatal rat cardiac myocytes

BMC Cell Biology

Volumn 5, Issue , 2004, Pages

  Chen, Zhihong ^a   Ge, Yinlin ^a   Kang, Jing X ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; RIBOZYME; SOMATOMEDIN B RECEPTOR; TUMOR NECROSIS FACTOR;

ADENOVIRUS; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; ENDOCYTOSIS; HEART DISEASE; HEART MUSCLE CELL; HYPOXIA; MITOGENESIS; NEWBORN; NONHUMAN; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; PROTEIN TRANSPORT; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RIBONUCLEASE PROTECTION ASSAY; VIRUS INFECTION; ANIMAL; CELL CULTURE; CELL DIVISION; CHEMISTRY; CYTOLOGY; GENE VECTOR; GENETICS; METABOLISM; NUCLEOTIDE SEQUENCE; PHYSIOLOGY;

ADENOVIRIDAE;

ADENOVIRIDAE; ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; BASE SEQUENCE; CELL DIVISION; CELLS, CULTURED; DOWN-REGULATION; GENETIC VECTORS; MYOCYTES, CARDIAC; RATS; RECEPTOR, IGF TYPE 2; RNA, CATALYTIC; RNA, MESSENGER;

EID: 10144231503     PISSN: 14712121     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-2121-5-15     Document Type: Article

References (36)

1. Kornfeild S: Structure and function of the mannose 6-phosphate/like growth factor II receptors. Annu Rev Biochem 1992, 61:307-330.
2. Ellis MJ, Leav BA, Yang Z, Rasmussen A, Pearce A, Zweibel JA, Lippman ME, Cullen KJ: Affinity for the insulin-like growth factor-II (IGF-II) receptor inhibits autocrine IGF-II activity in MCF-7 breast cancer cells. Mol Endocrinol 1996, 1:286-297.
3. Dennis PA, Rifkin DB: Cellular Activation of Latent Transforming Growth Factor β Requires Binding to the Cation-Independent Mannose 6-Phosphate/ Insulin-Like Growth Factor Type II Receptor. Proc Natl Acad Sci USA 1991, 88:580-584.
4. Dahms NM, Lobel P, Kornfeld S: Mannose 6-phosphate receptors and lysosomal enzyme targeting. J Biol Chem 1989, 264:12115-12118.
5. Nolan CM, Sly WS: Intracellular traffic of the mannose 6-phosphate receptor and its ligands. Adv Exp Med Biol 1987, 225:199-212.
6. Zang Y, Beard RL, Chandraratna RS, Kang JX: Evidence of a lysosomal pathway for apoptosis induced by the synthetic retinoid CD437 in human leukemia HL-60 cells. Cell Death Diff 2001, 8: 77-485.
7. DaCosta SA, Schumaker LM, Ellis MJ: Mannose 6-phosphate/insulin-like growth factor 2 receptor, a bona fide tumor suppressor gene or just a promising candidate? J Mammary Gland Biol Neoplasia 2000, 5:85-94.
8. Hajjar RJ, Monte FD, Matsui T, Rosenzweig A: Prospects for gene therapy in heart failure. Circulation Res 2000, 86: 16-621.
9. Lau ME, Stewart CE, Liu Z, Bhatt H, Rotwein P, Stewart CL: Loss of the imprinted IGF2/cation-independent mannose 6-phosphate phosphate receptor results in fetal overgrowth and perinatal lethality. Genes Dev 1994, 8:2953-2963.
10. Wang Z, Fung MR, Barlow DP, Wagner EF: Regulation of embryonic growth and lysosomal targeting by the imprinted IGF2/MPR gene. Nature 1994, 372:2585-2588.
11. Noguiera JB: Hypertensive cardiopathy. From arterial hypertension to congestive heart failure. Rev Port Cardiol 1999, 18:635-646.
12. Souza ATD, Hankins GR, Washington MK, Orton TC, Jirtle RL: M6P/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity. Nat Genet 1995, 11:447-449.
13. Hankins GR, Souza ATD, Bentley RC, et al.: M6P/IGF2 receptor: a candidate breast tumor suppressor gene. Oncogene 1996, 12:2003-2009.
14. Yamada T, Souza ATD, Finkelstein S, Jirtle RL: Loss of the gene encoding mannose 6-phosphate/insuline-like growth factor II receptor is an early event in liver carcinogenesis. Proc Natl Acad Sci USA 1997, 94:10351-10355.
15. Kong FM, Anscher MS, Washington M, Killian JK, Jirtle RL: M6P/IGF2R is mutated in squamous cell carcinoma of the lung. Oncogene 2000, 19:1572-1578.
16. James HA, Gibson I: The therapeutic potential of ribozymes. Blood 1998, 91:371-382.
17. Birikh KR, Heaton PA, Eckstein F: The structure, function and application of the hammerhead ribozyme. Eur J Biochem 1997, 245:1-16.
18. Rossi JJ: Therapeutic applications of catalytic antisense RNAs (ribozymes). Ciba Found Symp 1997, 209:195-204.
19. Dalla LL, Sabbadini R, Renken C: Apoptosis of the skeletal muscle of rats with heart failure is associated with increased serum levels of TNF-alpha and sphingosine. J Mol Cell Cardiol 2001, 33:1871-1878.
20. Nissley P, Kiess W, Sklar M: Developmental expression of the IGF-II/Mannose 6-phosphate receptor. Mol Reprod Dev 1993, 35:408-413.
21. MacLellan WR, Schneider MD: Genetic Dissection of cardiac growth control pathways. Annu Rev Physiol 2000, 62: 89-319.
22. Deiss LP, Galinka H, Berissi H, Cohen O, Kimchi A: Cathepsin D protease mediates programmed cell death induced by interferon-g, Fas/APO-1, and TNF-a. EMBO J 1996, 15: 861-3870.
23. Roberg K, Ollinger K: Oxidative stress causes relocation of lysosomal cathepsin D with ensuing apoptosis in neonatal rat cardiomyocytes. Am J Pathol 1998, 152:1151-1156.
24. Roberts LR, Adjei PN, Gores GJ: Cathepsins as effector proteases in hepatocyte apoptosis. Cell Biochem Biophys 1999, 30:71-88.
25. Ridout RM, Wildenthal K, Decker RS: Lysosomal responses of fetal mouse heart recovering from anoxia. J Mol Cell Cardiol 1986, 18:853-865.
26. Guicciardi ME, Miyoshi H, Bronk SF, Gores GJ: Cathepsin B knockout mice are resistant to tumor necrosis factor-alpha-mediated hepatocyte apoptosis and liver injury: implications for therapeutic applications. Am J Pathol 2001, 159:2045-2054.
27. Gabrielescu E, Butur G, Nicolau N, Giobanu A, Nutu O: Histochemical investigation of myocardial proteases in heart anoxia, under protection with cardioplegic solution and protease inhibitors. Physiologie 1989, 26:101-110.
28. Chao CC, Hu S, Sheng WS, Tsang M, Peterson PK: Tumor necrosis factor-alpha mediates the release of bioactive transforming growth factor-beta in murine microglial cell cultures. Clin Immunol Immunopathol 1995, 77:358-365.
29. Danforth DN Jr, Sgagias MK: Tumor necrosis factor alpha enhances secretion of transforming growth factor beta in MCF-7 breast cancer cells. Clin Cancer Res 1996,2:827-835.
30. Tobin SW, Brown MK, Douville K, Payne DC, Eastman A, Arrick BA: Inhibition of transforming growth factor signaling in MCF-7 cells results in resistance to tumor necrosis factor: a role for Bcl-2. Cell Growth Diff 2001, 12:109-117.
31. Sanderson N, Factor V, Nagy P: Hepatic expression of mature transforming growth factor b1 in transgenic mice results in multiple tissue lesions. Proc Natl Acad Sci USA 1995, 92: 572-2576.
32. He TC, Zhou S, Costa LT da, Yu J, Kinzler KW: A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci USA 1998, 95:2509-2514.
33. Kang ZB, Ge Y, Chen Z, Cluette-Brown J, Laposata M, Leaf A, Kang JX: Adenoviral gene transfer of Caenorhabditis elegans n3 fatty acid desaturase optimizes fatty acid composition in mammalian cells. Proc Natl Acad Sci USA 2001, 98:4050-4054.
34. Minniti CP, Koho EC, Grubb JH, Sly WS, Oh Y, Muller HI, Rosenfeld RG, Helman LJ: The insulin-like growth factorII (IGF-II)/mannose 6-phosphate receptor mediates IGF-II-induced motility in human rhabdomyosrcoma cells. J Biol Chem 1992, 267: 000-9004.
35. Szebenyi G, Rotwein P: Differential regulation of mannose 6-phosphate receptors and their ligands during the myogenic development of C2 cells. J Biol Chem 1991, 266:5534-5539.
36. Oshima A, Nolan CM, Kyle JW, Grubb JH, Sly WS: The human cation-independent mannose 6-phosphate receptor. Cloning and sequence of the full-length cDNA and expression of functional receptor in COS cells. J Biol Chem 1988, 263:2553-2562.